The Deal at a Glance

On June 22, 2026, Danone announced it had entered into a definitive agreement to acquire Made Group, the Melbourne-headquartered functional food and beverage company, from private equity firm TPG Capital. The deal, valued at approximately AU$2 billion (US$1.4 billion) according to Australia's Financial Review, brings Made's portfolio — anchored by Cocobella coconut water and Rokeby protein smoothies — fully into Danone's Essential Dairy and Plant-Based (EDP) division. Danone did not disclose official financial terms.

In a separate but concurrent move, Danone also announced it would acquire the remaining 49% stake in its existing fresh dairy joint venture with Saputo Dairy Australia, taking full operational control of a business already marketing Danone's YoPRO, Activia, and Ultimate brands across the Australian market. Both transactions are expected to close in the second half of 2026, subject to regulatory approvals. Together, the two deals represent Danone's most decisive commitment yet to the APAC region's fast-growing health nutrition space.

Who Is Made Group?

Founded in Melbourne in 2005, Made Group has built one of Australia's most coherent functional food and beverage platforms. Its portfolio spans five distinct consumer propositions: Cocobella (Australia's number-one coconut water and plant-based yoghurt brand, with significant traction across Southeast Asia); Rokeby Farms (ultra-filtered protein smoothies, probiotic yoghurt, and high-protein milk, sourced from Gippsland dairy farms); Impressed (cold-pressed juices); NutrientWater (vitamin-enhanced hydration); and The Collective, a New Zealand-born premium yoghurt brand with European distribution.

The company operates an integrated model spanning in-house manufacturing, sourcing, packaging, and distribution — a structure that Danone's Deputy CEO Juergen Esser described as a "mini Danone" given its simultaneous strengths across high-protein dairy, plant-based alternatives, and functional hydration. Majority-owned by TPG Capital since 2021, Made has delivered double-digit revenue growth and healthy margins, reaching over €300 million in revenue for the fiscal year ending June 2026.

The Renew Strategy in Full Motion

The Made Group acquisition is not a standalone bet — it is the latest execution of a methodical portfolio transformation under Danone's Renew Strategy, launched to restore competitive growth and drive long-term value creation. Since mid-2025, Danone has completed four significant acquisitions in under 14 months, each targeting a distinct node within the functional nutrition ecosystem.

The sequence began with Kate Farms, a US-based organic medical nutrition company, followed by The Akkermansia Company, a Belgian microbiome biotech whose science underpins next-generation gut health applications. In March 2026, Danone announced the acquisition of Huel — the UK-based plant-based complete nutrition brand with strong direct-to-consumer capabilities in Europe and North America — for approximately €1 billion. The Huel deal remains under review by the UK Competition and Markets Authority. Now, with Made Group, Danone adds an APAC platform built on drinkable protein and coconut-based wellness formats.

Collectively, these four transactions have committed well over US$2.5 billion to functional nutrition and beverage assets — a clear signal that Danone under Antoine de Saint-Affrique is treating inorganic growth not as opportunistic but as structurally required to compete in a market where legacy dairy formats alone cannot sustain a premium valuation.

Why Drinkable Formats Are Winning

The strategic logic behind Made — and behind much of Danone's recent M&A — rests on a structural shift in how consumers engage with health nutrition. Drinkable formats innovate faster, are consumed more frequently, and occupy higher-frequency purchase occasions than traditional spoonable yoghurt. They also sit at the intersection of three compounding consumer trends: the mainstreaming of high-protein diets, the rising adoption of GLP-1 weight-loss medications (which sharply increase demand for high-protein, nutrient-dense foods), and the out-of-home convenience premium.

Rokeby's ultra-filtered protein milk and Cocobella's coconut water align with a Danone portfolio already leaning heavily into protein and gut health. The addition of Made reinforces a portfolio logic where Alpro addresses European plant-based shoppers, Huel serves active nutrition communities in the UK and US, and Made becomes the platform for protein and wellness hydration across Australia and Southeast Asia — the next proving ground for plant-based and functional beverages after Europe and North America.

The transaction also represents a test of geographic arbitrage: Alpro has won decisively in Europe; Silk has underperformed in the US; APAC is now Danone's next ambition. Made's established commercial infrastructure across Australia, New Zealand, and Southeast Asia gives Danone a distribution beachhead that would have taken years to build organically.

The M&A Playbook: Why This Deal Works

The Made Group transaction fits a disciplined acquisition framework gaining traction across global FMCG: mid-sized deals (US$0.5–5B range), in high-growth categories the acquirer already understands, with assets that can be plugged into existing go-to-market infrastructure and synergy engines. This is not a transformative bet on an unfamiliar market — it is a targeted bolt-on into a category and geography where Danone already has brand presence, R&D capability, and commercial relationships.

For TPG Capital, the exit validates the private equity model in food and beverage: acquire a founder-built platform with authentic brand equity, accelerate growth through operational investment, and sell into a strategic buyer willing to pay a premium for category leadership. TPG's exit at approximately AU$2 billion — roughly five years after its 2021 entry — represents a compelling return on a business it supported through its most aggressive growth phase.

Made CEO Amanda Butler will remain in her role post-acquisition, a strong signal of operational continuity. Butler has framed the deal as an access story: Danone's infrastructure, R&D expertise, and global reach are expected to accelerate Made's expansion across the wider APAC region — particularly into markets where Danone already has established distribution.

Implications for MENA and Saudi Arabia

For food and beverage companies and investors across Saudi Arabia and the MENA region, the Danone-Made transaction carries important strategic signals. The deal is not geographically proximate to the Gulf, but its commercial logic resonates directly with trends reshaping the Saudi market: rising consumer demand for protein-enriched products, explosive growth in functional hydration, and a rapidly maturing market for gut health and wellness beverages.

Saudi Arabia's functional beverage category has seen consistent double-digit growth in recent years, driven by a young, health-conscious population, gym culture penetration, and growing awareness of protein intake — trends that track closely with the dynamics that made Made Group attractive to Danone in Australia. The Vision 2030 agenda's focus on preventive health and food security provides a structural tailwind for domestic players developing products in these categories.

For MENA investors and M&A strategists, the transaction also reinforces a clear valuation signal: businesses with authentic health positioning, proprietary formats, and double-digit growth are commanding premium acquisition multiples globally. Saudi and Gulf food companies building in the functional nutrition space — whether in high-protein dairy, gut health products, or botanical beverages — are operating in a category that global strategics are actively prioritizing for portfolio expansion. That makes regional innovation in these formats not just commercially attractive but strategically relevant to potential partnerships and exits.

Editorial View

The pattern is now unmistakable. PepsiCo, Coca-Cola, Nestlé, and Danone are all moving capital toward the same destination: protein, gut health, and functional beverages. The Made Group deal is the latest data point in a reallocation of FMCG capital that has been underway for several years but has accelerated sharply in 2025–2026, partly catalyzed by the GLP-1 pharmaceutical wave and its downstream effects on food consumption patterns.

What distinguishes Danone's approach is its coherence. Rather than chasing scale for its own sake, the Renew Strategy has produced a portfolio with genuine thematic integrity: from Akkermansia's microbiome science to Huel's complete nutrition to Made's protein and coconut wellness range. Each acquisition adds a distinct capability or geography without diluting the core narrative. For Danone shareholders — and for observers tracking global food sector M&A — the question is no longer whether the strategy is credible. It is whether integration at speed can preserve the cultural agility and brand authenticity that made these acquisitions worth paying for in the first place.